ORIC-944
ORIC-944-01
Phase 1 small_molecule active
Quick answer
ORIC-944 for Metastatic Prostate Cancer is a Phase 1 program (small_molecule) at Oric Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Oric Pharmaceuticals
- Indication
- Metastatic Prostate Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active